Data as of Dec 11
| +0.10 / +1.42%|
The 6 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 5.50. The median estimate represents a -1.82% decrease from the last price of 7.13.
The current consensus among 7 polled investment analysts is to Hold stock in Cross Country Healthcare Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.